Phoenixus AG on Muck Rack

Phoenixus AG

As seen in: Longview News-Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Phoenixus

Contact Phoenixus, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Vyera Pharmaceuticals, LLC and Phoenixus AG Sign Asset Purchase Agreement to Sell Rights to Daraprim and Vecamyl

|
By Phoenixus AG
| Longview News-Journal Verified
, /PRNewswire/ -- Vyera Pharmaceuticals, LLC ("Vyera") and Phoenixus AG ("Phoenixus") today announced that they have entered into an Asset Purchase Agreement related to Daraprim and Vecamyl. The aggregate consideration to be paid for the sale and transfer of the purchased assets and the assignment of the certain contracts, subject to adjustment, shall be $650,000 together with the assumption of post-closing liabilities.
Open in Who Shared View Duplicates (287) Issue with article?

Vyera Pharmaceuticals, LLC

|
By Phoenixus AG, Martin Shkreli, Kevin Mulleady
| Federal Trade Commission
Last Updated: January 14, 2022 Case Status: Pending Federal Trade Commission and State of New York, Plaintiffs v.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified